Organ and species specificity of Hepatitis B Virus (HBV) infection: A review of literature with a special reference to preferential attachment of HBV to human hepatocytes

Journal of Viral Hepatitis

Volumn 4, Issue 3, 1997, Pages 145-154

  De Meyer, S ^a   Gong, Z J ^a   Suwandhi, W ^a,b   Van Pelt, J ^a   Soumillion, A ^a   Yap, S H ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b University of Catholic Atmajaya   (Indonesia)

Author keywords

Annexin V; Attachment sites; Hepatitis B virus; PreS1; PreS2; Small HBsAg

Indexed keywords

ANIMAL; ANTIBODY SPECIFICITY; CYTOLOGY; GENETIC TRANSCRIPTION; GENETICS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER; PATHOGENICITY; RAT; REVIEW; SPECIES DIFFERENCE; ULTRASTRUCTURE; VIROLOGY; VIRUS GENOME;

ANIMALS; GENOME, VIRAL; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LIVER; ORGAN SPECIFICITY; RATS; SPECIES SPECIFICITY; TRANSCRIPTION, GENETIC;

EID: 0031131799     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.1997.00126.x     Document Type: Review

References (93)

1. Blumberg B, Alter H, Visnich S. A 'new' antigen in leukemia sera. J Am Med Assoc 1965; 191: 101-106.
2. Kane M. Progress on the control of hepatitis B infection through immunisation. Gut 1993; 34(Suppl 2): S10-S12.
3. Bosch FX, Munoz N. Hepatocellular carcinoma in the world: epidemiologic questions. Adv Appl Biotechnol Series 1991; 13: 35-56.
4. Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet 1981; 2: 1129-1133.
5. Robinson WS, Marion PL, Feitelson M, Siddiqui A. The hepadna virus group: hepatitis B and related viruses. In: Szmuness W et al. eds. Viral Hepatitis. Philadelphia: Franklin Institute Press, 1982: 57-68.
6. Ge X, Huang GY, Jie C et al. Studies on experimental infection on those species of wild monkey with human hepatitis B virus. International Symposium on Viral Hepatitis and Liver Disease. Tokyo, 117.
7. Gerlich W, Robinson W. Hepatitis B virus contains protein attached to the 5′-terminus of its complete DNA strand. Cell 1980; 21: 801-809.
8. Albin C, Robinson W. Protein kinase activity in hepatitis B virus. J Virol 1980; 34: 297-302.
9. Summers J, O'Connell A, Millman I. Genome of hepatitis B virus: restriction enzyme cleavage and structure of DNA extracted from Dane particles. Proc Natl Acad Sci USA 1975; 72; 4597-4601.
10. Hruska J, Clayton D, Rubenstein J, Robinson W. Structure of hepatitis B Dane particle DNA before and after the Dane particle DNA polymerase reaction. J Virol 1977; 21: 666-672.
11. Landers T, Greenberg H, Robinson W. Structure of hepatitis B Dane particle DNA and nature of the endogenous DNA polymerase reaction. J Virol 1977; 23: 368-376.
12. Delius H, Gough N, Cameron C, Murray K. Structure of the hepatitis B virus genome. J Virol 1983; 47: 337-343.
13. Sattler F, Robinson W. Hepatitis B viral DNA molecules have cohesive ends. J Virol 1979; 32: 226-233.
14. Köck J, Theilmann L, Galle P, Schlicht HJ. Hepatitis B virus nucleic acids associated with human peripheral blood mononuclear cells do not originate from replicating virus. Hepatology 1996; 23: 405-413.
15. Robinson WS, Miller RH, Marion PL. Hepadnaviruses and retroviruses share homology and features of replication. Hepatology 1987; 7: S64-S73.
16. Heermann K, Goldmann U, Schwartz W, Seyffarth T, Baumgarten H, Gerlich W. Large surface proteins of hepatitis B virus containing the preS sequence. J Virol 1984; 52: 396-402.
17. Molnar-Kimber K, Summers J, Mason W. Mapping of the cohesive overlap of duck hepatitis B virus DNA and of the site of initiation of reverse transcription. J Virol 1984; 51: 181-191.
18. Tiollais P, Pourcel C, Dejean A. The hepatitis B virus. Nature 1985; 317: 489-195.
19. Summers J, Mason W. Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell 1982; 29: 403-415.
20. Michel M, Tiollais P. Structure and expression of the hepatitis B virus genome. Hepatology 1987; 7 (Suppl): S61-S63.
21. Galibert F, Mandart E, Fitoussi F, Tiollais P, Charnay P. Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli. Nature 1979; 281: 646-650.
22. Kay A, Mandart E, Trepo C, Galibert F. The HBV HBX gene expressed in E. coli is recognized by sera from hepatitis patients. EMBO J 1985; 4: 1287-1292.
23. Levrero M, Jean-Jean O, Balsano C, Will H, Perricaud M. Hepatitis B virus (HBV) X gene expression in human cells and anti-HBX antibodies detection in chronic HBV infection. Virology 1990; 174: 299-304.
24. Haruna Y, Hayashi N, Katayama K et al. Expression of X protein and hepatitis B virus replication in chronic hepatitis. Hepatology 1991; 13: 417-421.
25. Wang WL, London WT, Feitelson MA. Hepatitis B x antigen in hepatitis B virus carrier patients with liver cancer. Cancer Res 1991; 51: 4971-4977.
26. Moriarty AM, Alexander H, Lerner RA, Thornton GB. Antibodies to peptides detect new hepatitis B antigen, serological correlation with hepatocellular carcinoma. Science 1985; 227: 429-433.
27. Kekule AS, Lauer U, Weiss L, Luber B, Hofschneider PH. Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway. Nature 1993; 361: 742-745.
28. Mason W, Halpern M, England J et al. Experimental transmission of duck hepatitis B virus. Virology 1983; 131: 375-384.
29. Maniatis T, Goodbourn S, Fisher J. Regulation of inducible and tissue-specific gene expression. Science 1987; 236: 1237-1245.
30. Ganem D, Varmus H. The molecular biology of the hepatitis B viruses. Annu Rev Biochem 1987; 56: 651-693.
31. Kaneko S, Miller RH. X region-specific transcript in mammalian hepatitis B virus-infected liver. J Virol 1988; 62: 3979-3984.
32. Bulla G, Siddiqui A. The hepatitis B virus enhancer modulates transcription of the hepatitis B virus surface antigen gene from an internal location. J Virol 1988; 62: 1437-1441.
33. Wang Y, Chen P, Wu X et al. A new enhancer element EN II identified in the X gene of hepatitis B virus. J Virol 1990; 64: 3977-3981.
34. Yuh CH, Ting LP. The genome of hepatitis B virus contains a second enhancer: cooperation of two elements within this enhancer is required for its function. J Virol 1990; 64: 4281-4287.
35. Yee JK. A liver specific enhancer in the core promoter region of human hepatitis B virus. Science 1989; 246: 658-661.
36. Standring D, Rutter W, Varmus H, Ganem D. Transcription of the hepatitis B surface antigen gene in cultured murine cells initiates within the pre-surface region. J Virol 1984; 50: 563-571.
37. Laub O, Rail LB, Truett M et al. Synthesis of hepatitis B surface antigen in mammalian cells: expression of the entire gene and the coding region. J Virol 1983; 48: 271-280.
38. Dubois M, Pourcel C, Rousset S, Chary C, Tiollais P. Excretion of hepatitis B surface antigen particles from mouse cells transformed with cloned viral DNA. Proc Natl Acad Sci USA 1980; 77: 4549-4553.
39. Sureau C, Romet-Lemonne J, Mullins JI, Essex M. Production of hepatitis B virus by a differentiated human hepatoma cell line after transfection with cloned circular HBV DNA. Cell 1986; 47: 37-47.
40. Tsurimoto T, Fujiyama A, Matsubara K. Stable expression and replication of hepatitis B virus genome in an integrated state in a human hepatoma cell line transfected with the cloned viral DNA. Proc Natl Acad Sci USA 1987; 84: 444-448.
41. Yaginuma K, Shirakata Y, Kobayashi M, Koike K. Hepatitis B virus (HBV) particles are produced in a cell culture system by transient expression of transfected HBV-DNA. Proc Natl Acad Sci USA 1987; 84: 2678-2682.
42. Raney AK, Milich DR, Mc Lachlan A. Characterization of hepatitis B virus major surface antigen gene transcriptional regulatory elements in differentiated hepatoma cell lines. J Virol 1989; 63: 3919-3925.
43. Karpen S, Banerjee R. Zelent A, Price P, Acs G. Identification of protein binding sites in the hepatitis B virus enhancer and core promoter domains. Mol Cell Biol 1988; 8: 5159-5165.
44. Ben-Levy R, Faktor O, Berger I, Shaul Y. Cellular factors that interact with the hepatitis B virus enhancer. Mol Cell Biol 1989; 9: 1804-1809.
45. Yaginuma K, Koike K. Identification of a promoter region for 3.6 kilobase mRNA of hepatitis B virus and specific cellular binding protein. J Virol 1989; 63: 2914-2920.
46. Patel N, Jameel S, Isom H, Siddiqui A. Interaction between nuclear factors and the hepatitis B virus enhancer. J Virol 1989; 63: 5293-5301.
47. Shih CH, Li LS, Roychoudhury S, Ho MH. In vitro propagation of human hepatitis B virus in a rat hepatoma cell line. Proc Natl Acad Sci USA 1989; 86: 6323-6327.
48. Farza H, Hadchouel M, Scotto J, Tiollais P, Babinet C, Pourcel CJ. Replication and gene expression of hepatitis B virus in a transgenic mouse that contains the complete viral genome. J Virol 1988; 62: 4144-1152.
49. Guidotti LG, Matzke B, Schaller H, Chisari FV. High level hepatitis B virus replication in transgenic mice. J Virol 1995; 69: 6158-6169.
50. Imai M, Yanase Y, Nojiri T, Miyakawa Y, Mayumi MA. A receptor for polymerized human and chimpanzee albumin on hepatitis B virus particles co-occuring with HBeAg. Gastroenterology 1979; 76: 242-247.
51. Machida A, Kishimoto S, Ohnuma H et al. A hepatitis B surface antigen polypeptide (P31) with the receptor for polymerized human as well as chimpanzee albumins. Gastroenterology 1983; 85: 268-274.
52. Ishihara K, Waters JA, Pignatelli M, Thomas HC. Characterization of the polymerised and monomeric human serum albumin binding sites on hepatitis B surface antigen. J Med Virol 1987; 21: 89-95.
53. Trevisan A, Gudat F, Guggenheim R et al. Demonstration of albumin receptors on isolated human hepatocytes by light and scanning electron microscopy. Hepatology 1982; 2: 832-835.
54. Wright TL, Lysenko N, Ockner RK, Weisiger RA. Interaction of natural and synthetic albumin polymers with hepatocytes. Hepatology 1987; 7: 294-301.
55. Yu MW, Finlayson JS, Shih JWK. Interaction between various polymerized human albumins and hepatitis B surface antigen. J Virol 1985; 55: 736-743.
56. Thung SN, Wang DF, Fasy TM, Hood A, Gerber MA. Hepatitis B surface antigen binds to human serum albumin cross-linked by transglutaminase. Hepatology 1989; 9: 726-730.
57. Krone B, Lenz A, Heermann KH, Seifer M, Lu X, Gerlich WH. Interaction between hepatitis B surface proteins and monomeric human serum albumin. Hepatology 1990; 11: 1050-1056.
58. Dash S, Rao KVS, Joshi B, Nayak NC, Panda SK. Significance of natural polymerized albumin and its receptor in hepatitis B infection of hepatocytes. Hepatology 1991; 13: 134-142.
59. Ponlisso P, Ruvoletto MG, Gerlich WH, Heermann KH, Bardini R, Alberti A. Identification of an attachment site for human liver plasma membranes on hepatitis B virus particles. Virology 1989; 173: 522-530.
60. Pontisso P, Petit MA, Bankowski MJ, Peeples ME. Human liver plasma membranes contain receptors for the hepatitis B virus pre-S1 region and, via polymerized human serum albumin, for the pre-S2 region. J Virol 1989; 63: 1981-1988.
61. Ncurath AR, Kent SBH, Parker K et al. Antibodies to a synthetic peptide from the preS 120-145 region of the hepatitis B virus envelope are virus neutralizing. Vaccine 1986; 4: 35-37.
62. Itoh Y, Takai E, Ohnuma H et al. A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees. Proc Natl Acad Sci USA 1986; 83: 9174-9178.
63. Tuttleman JS, Pugh JC, Summers JW. In vitro experimental infection of primary duck hepatocyte cultures with duck hepatitis B virus. J Virol 1986; 58: 17-25.
64. Thomas H, Jacyna M, Waters J, Main J. Virus-host interaction in chronic hepatitis B virus infection. Semin Liver Dis 1988; 8: 342-349.
65. Geruch WH. Hepatitis B surface proteins. J Hepatol 1991; 13: S90-S92.
66. Gerlich WH, Lu X, Heermann KH. Studies on the attachment and penetration of hepatitis B virus. J Hepatol 1993; 17(Suppl.3): S10-S14.
67. Budkowska A, Bedossa P, Groh F, Louise A, Pillot J. Fibronectin of human liver sinusoids binds hepatitis B virus: identification by an anti-idiotypic antibody bearing the internal image of the preS2 domain. J Virol 1995; 69: 840-848.
68. Franco A, Paroli M, Testa U et al. Transferrin receptor mediates uptake and presentation of hepatitis B envelope antigen by T lymphocytes. J Exp Med 1992; 175: 1195-1205.
69. Petit MA, Dubanchet S, Capel F, Voet P, Dauguet C, Hauser P. HepG2 cell binding activities of different hepatitis B virus isolates: inhibitory effect of anti-HBs and anti-preS1(21-47). Virology 1991; 180: 483-491.
70. Petit MA, Strick N, Dubanchet S, Capel F, Neurath AR. Inhibitory activity of monoclonal antibody F35.25 on the interaction between hepatocytes (HepG2 cells) and preS1-specific ligands. Mol Immunol 1991; 28: 517-521.
71. Petit MA, Capel F, Dubanchet S, Mabit H. PreS1-specific binding proteins as potential receptors for hepatitis B virus in human hepatocytes. Virology 1992; 187: 211-222.
72. Duclos-Vallée JC, Mabit H, Capel F, Dubanchet S, Petit MA. Multiple enzyme activities of human liver glyceraldehyde-3-phosphate dehydrogenase (GAPD): involvement in early steps of the hepatitis virus (HBV) replication cycle. American Association for the Study of Liver Diseases, Chicago. Hepatology, 1995; 22: p 269A Abstract 651.
73. Neurath AR, Strick N. Antigenic mimicry of an immunoglobulin A epitope by a hepatitis B virus cell attachment site. Virology 1990; 178: 631-634.
74. Pontisso P, Ruvoletto MG, Tiribelli C, Gerlich WH, Ruol A, Alberti A. The preS1 domain of hepatitis B virus and IgA cross-react in their binding to the hepatocyte surface. J Gen Virol 1992; 73: 2041-2045.
75. Neurath AR, Strick N, Sproul P. Search for hepatitis B virus cell receptors reveals binding sites for interleukin 6 on the virus envelope protein. J Exp Med 1992; 175: 461-469.
76. Neurath AR, Strick N, Li Y. Cells transfected with human interleukin 6 cDNA acquire binding sites for the hepatitis B virus envelope protein. J Exp Med 1992; 176: 1561-1569.
77. Treichel U, Meyer zum Büschenfelde K, Gerken G. Hepatitis B virus infection in vitro mediated by endocytosis via the asialoglycoprotein receptor. J Hepatol 1993; 18 (Suppl. 1): S20.
78. Treichel U, Meyer zum Büschenfelde K, Gerken G. HBs antigen secretion by human hepatoma cells after binding and endocytosis of natural HBV particles via the asialoglycoprotein receptor. Hepatology 1993; 18 (Suppl. 4): 117A.
79. Treichel U, Meyer zum Büschenfelde K, Stockert RJ, Poralla T, Gerken G. The asialoglycoprotein receptor mediates hepatic binding and uptake of natural hepatitis B virus particles derived from viraemic carriers. J Gen Virol 1994; 75: 3021-3029.
80. Dash S, Rao KVS, Panda SK. Receptor for preS1(21-47) component of hepatitis B virus on the liver cell: role in virus cell interaction. J Med Virol 1992; 37: 116-121.
81. Budkowska A, Quan C, Groh F et al. Hepatitis B virus (HBV) binding factor in human serum: candidate for a soluble form of hepatocyte HBV receptor. J Virol 1993; 67: 4316-4322.
82. Neurath R, Strick N, Kent S, Parker K, Seto B, Girard M. Design of synthetic peptides mimicking the immunologic and biologic functions of the preS1 sequence of the hepatitis B virus envelope protein. In: Ginsberg H, Brown F, Lerner RA, Chanack R, eds. Vaccine 88. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press, 1988: 229-234.
83. Thronton G, Moriarty A, Millich D, Eichberg J, Purcell R, Gerin J. Protection of chimpanzees from hepatitis B virus infection after immunization with synthetic peptides: identification of protective epitopes in the pre-S region. In: Lernen R, Ginsberg H, Chanack R, Brown F, eds. Vaccine 89. Modern approaches to new vaccines including prevention of AIDS. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press, 1989: 467-472.
84. 2-glycoprotein I: molecular properties of an unusual apolipoprotein, apolipoprotein H. J Biol Chem 1983; 258: 4765-4770.
85. Machida A, Kishimoto S, Ohnuma H et al. A hepatitis B surface antigen polypeptide (p31) with the receptor for polymerized human as well as chimpanzee albumins. Gastroenterology 1983; 85: 268-274.
86. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988; 240: 622-640.
87. Kambouris AM, Roach PD, Calvert GD, Nestel PJ. Retroendocytosis of high density lipoproteins by the human hepatoma cell line, HepG2. Arteriosclerosis 1990; 10: 582-590.
88. Mehdi H, Kaplan MJ, Anlar FY et al. Hepatitis B virus surface antigen binds to apolipoprotein H. J Virol 1994; 68: 2415-2424.
89. Mehdi H, Yang X, Peeples ME. An altered form of apolipoprotein H binds hepatitis B virus surface antigen most efficiently. Virology 1996; 217: 58-66.
90. Leenders WPJ, Glansbeek HL, De Bruin WCC, Yap SH. Binding of the major and large HBsAg to human hepatocytes and liver plasma membranes: Putative external and internal receptors for infection and secretion of hepatitis B virus. Hepatology 1990; 12: 141-147.
91. Hertogs K, Leenders WPJ, Depla E et al. Endonexin II, present on human liver plasma membranes, is a specific binding protein of small hepatitis B virus (HBV) envelope protein. Virology 1993; 197: 549-557.
92. 2 fragment of anti-human liver endonexin II immunoglobin G: evidence for a receptor-ligand-like relationship between small hepatitis B surface antigen and endonexin II. J Virol 1994; 68: 1516-1521.
93. Gong ZJ, van Pelt JF, Hertogs K, Depla E, De Meyer S, Yap SH. Evidence for a direct involvement of human liver annexin V in the initial step of hepatitis B virus infection Proceedings of the IX Triennial International Symposium on Viral Hepatitis and Liver Disease. Rome, 1996: p 15 Abstract 43.